Venkat Pharma Ltd - Stock Valuation and Financial Performance

Name: Venkat Pharma
Brand: Venkat Pharma

BSE: 532093 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Venkat Pharma

Based on:

Data

M-Cap below 100cr DeciZen not available

Venkat Pharma stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

1.7 Cr.

52-wk low:

3.4

52-wk high:

3.7

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Venkat Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'00	Mar'01	Mar'02	Mar'03	Mar'04	Mar'05	Mar'10	Mar'11	Mar'12	Mar'13	TTM
ROCE % ⓘ	4%	1.3%	5.9%	0%	4.9%	7.2%	-1.5%	-0.5%	-0.2%	-0.3%	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	19.7	41.7	51.9	0	47.8	36.4	0	0	0	0	0
Sales YoY Gr.	-	111.5%	24.5%	-100%	NA	-23.9%	-100%	NA	NA	NA	-
Adj EPS ⓘ	0.2	0.1	0.9	0	0.4	0.5	-0.5	-0.1	-0.1	-0.1	-0.1
YoY Gr.	-	-50%	1075%	-100%	NA	14.3%	-206.3%	NA	NA	NA	-
BVPS (₹) ⓘ	10.7	10.8	11.8	0	14.6	15.1	-4.8	-4.9	-5	-5.1	-5.2
Adj Net Profit ⓘ	0.1	0	0.3	0	0.2	0.2	-0.3	-0.1	0	0	0
Cash Flow from Ops. ⓘ	0.9	-0.8	0.3	0	-1.5	0.3	0	0	0	0	-
Debt/CF from Ops. ⓘ	2.7	-2.7	6.5	0	-4.7	43.9	-6228.5	-12457	-1536.2	-14785.4	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-100%	-100%	NA	NA
Adj EPS ⓘ	-193.8%	-173.5%	NA	NA
BVPSⓘ	-192.1%	-181%	NA	NA
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'00	Mar'01	Mar'02	Mar'04	Mar'05	Mar'10	Mar'11	Mar'12	Mar'13	TTM
Return on Equity % ⓘ	1.4	0.7	8	3.5	3.2	-11.2	2.7	1.5	1.8	1
Op. Profit Mgn % ⓘ	2.7	0.7	1.2	2	5.3	0	0	0	0	NAN
Net Profit Mgn % ⓘ	0.3	0.1	0.6	0.4	0.6	0	0	0	0	-INF
Debt to Equity ⓘ	0.7	0.6	0.5	1.1	1.8	-6.8	-6.6	-7.7	-7.6	3.8
Working Cap Days ⓘ	0	251	206	189	240	0	0	0	0	0
Cash Conv. Cycle ⓘ	0	46	46	80	162	0	0	0	0	0

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Venkat Pharma Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-0.1	-
TTM Sales (₹ Cr.)	0	-
BVPS (₹.) ⓘ	-5.2	-
Reserves (₹ Cr.) ⓘ	-8	-
P/BV ⓘ	-0.66	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	3.40 / 3.72
All Time Low / High (₹)	1.39 / 66.80
Market Cap (₹ Cr.)	1.7
Equity (₹ Cr.)	5
Face Value (₹)	10
Industry PE ⓘ	48.8

Management X-Ray of Venkat Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Venkat Pharma

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Venkat Pharma

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'00	Mar'01	Mar'02	Mar'04	Mar'05	Mar'10	Mar'11	Mar'12	Mar'13
Sales	19.71	41.68	51.90	47.83	36.42	0	0	0	0
Operating Expenses ⓘ	19.18	41.39	51.30	46.89	34.50	0.21	0.04	0.02	0.03
Manufacturing Costs	0.37	37.61	42.15	5.69	5.36	0	0	0	0
Material Costs	17.35	-0.05	0.21	34.34	23.83	0	0	0	0
Employee Cost	0.13	0.13	0.79	0.45	0.54	0.02	0.02	0	0
Other Costs ⓘ	1.33	3.70	8.16	6.41	4.76	0.19	0.02	0.02	0.03
Operating Profit ⓘ	0.53	0.29	0.60	0.93	1.93	-0.21	-0.04	-0.02	-0.03
Operating Profit Margin (%)	2.7%	0.7%	1.1%	2.0%	5.3%	-	-	-	-
Other Income ⓘ	0.04	0.13	0.13	0.02	0	0	0	0	0
Interest ⓘ	0.28	0.08	0.05	0.43	1.37	0	0	0	0
Depreciation ⓘ	0.22	0.28	0.29	0.18	0.26	0.04	0.02	0.02	0.02
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0.07	0.06	0.38	0.34	0.30	-0.24	-0.06	-0.04	-0.04
Tax ⓘ	0.01	0.03	0.05	0.15	0.08	0.01	0	0	0
Profit After Tax	0.05	0.03	0.33	0.19	0.22	-0.25	-0.06	-0.04	-0.04
PAT Margin (%)	0.3%	0.1%	0.6%	0.4%	0.6%	-	-	-	-
Adjusted EPS (₹)	0.2	0.1	0.9	0.4	0.5	-0.5	-0.1	-0.1	-0.1
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'00	Mar'01	Mar'02	Mar'04	Mar'05	Mar'10	Mar'11	Mar'12	Mar'13
Equity and Liabilities
Shareholders Fund	3.90	3.92	4.25	6.68	6.89	-2.38	-2.44	-2.50	-2.54
Share Capital ⓘ	3.50	3.50	3.50	4.53	4.53	4.99	4.99	4.99	4.99
Reserves ⓘ	0.40	0.42	0.75	2.15	2.37	-7.36	-7.43	-7.48	-7.53
Minority Interest	0	0	0	0	0	0	0	0	0
Debt	2.52	2.09	1.96	7.10	12.13	16.19	16.19	19.20	19.22
Long Term Debt	2.52	2.09	1.96	7.10	12.13	16.19	16.19	19.20	19.20
Short Term Debt	0	0	0	0	0	0	0	0	0.02
Trade Payables	21.89	23.54	19.85	5.95	2.51	4.08	4.08	0.53	0.53
Others Liabilities ⓘ	0.20	3.36	3.85	3.49	6.53	0.26	0.18	0.75	0.65
Total Liabilities ⓘ	28.50	32.91	29.92	23.21	28.06	18.16	18.01	17.99	17.87
Fixed Assets
Gross Block	2.86	3.26	3.43	3.66	3.73	3.72	3.72	3.71	3.71
Accumulated Depreciation	1.05	1.34	1.63	2.10	2.30	2.80	2.83	2.84	2.86
Net Fixed Assetsⓘ	1.81	1.92	1.80	1.57	1.42	0.92	0.89	0.87	0.85
CWIP ⓘ	0	0	0	0	0	0	0	0	0
Investmentsⓘ	0	0	0	0	0	0	0	0	0
Inventories	1	1.04	0.84	2.20	7.09	2.14	2.14	2.14	2.02
Trade Receivables	25.38	28.84	26.78	17.20	14.79	12.74	12.73	12.73	12.73
Cash Equivalents	0.03	0.07	0.07	0.06	0.22	0.02	0.02	0.01	0.01
Others Assetsⓘ	0.29	1.04	0.44	2.18	4.54	2.35	2.24	2.25	2.25
Total Assets ⓘ	28.50	32.91	29.92	23.21	28.06	18.16	18.01	17.99	17.87

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'00	Mar'01	Mar'02	Mar'04	Mar'05	Mar'10	Mar'11	Mar'12	Mar'13
Cash Flow From Operating Activity ⓘ	0.92	-0.78	0.30	-1.51	0.28	0	0	-0.01	0
PBT ⓘ	0.07	0.23	0.38	0.33	0.30	-0.24	-0.06	-0.04	-0.04
Adjustment ⓘ	0.52	0.37	0.35	0.21	0.28	0.04	0.02	0.02	0.02
Changes in Working Capital ⓘ	0.62	-1.31	-0.39	-1.9	-0.19	0.21	0.04	0.01	0.03
Tax Paid ⓘ	0	0	0	-0.14	-0.11	-0.01	0	0	0
Cash Flow From Investing Activity ⓘ	-0.52	0.39	-0.17	-0.09	-0.12	0	0.01	0.01	0
Capex	-0.52	0	-0.17	-0.09	-0.12	0	0.01	0.01	0
Net Investments	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0.39	0	0	0	0	0	0	0
Cash Flow From Financing Activityⓘ	-0.38	0.43	-0.13	1.03	0	0	0	0	0
Net Proceeds from Shares ⓘ	0	0	0	1.03	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-0.38	0.43	-0.13	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0	0	0
Net Cash Flow ⓘ	0.02	0.04	0	-0.57	0.15	0	0	-0.01	0

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'00	Mar'01	Mar'02	Mar'04	Mar'05	Mar'10	Mar'11	Mar'12	Mar'13
Ratios
ROE (%)	1.45	0.74	8.29	3.55	3.24	N/A	N/A	N/A	N/A
ROCE (%)	5.57	2.23	7.16	7.77	10.2	N/A	N/A	N/A	N/A
Asset Turnover Ratio	0.69	1.36	1.65	1.8	1.42	0	0	0	0
PAT to CFO Conversion(x)	18.4	-26	0.91	-7.95	1.27	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	470	237	196	168	160	0	0	0	0
Inventory Days	18	9	7	12	47	0	0	0	0
Payable Days	460	0	0	137	65	0	0	0	0

Venkat Pharma Ltd Stock News

Venkat Pharma Ltd FAQs

What is the share price of Venkat Pharma?

Company share prices are keep on changing according to the market conditions. The closing price of Venkat Pharma on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Venkat Pharma?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Venkat Pharma stood at ₹1.70.

What is the P/E ratio of Venkat Pharma?

The latest P/E ratio of Venkat Pharma as of 01-Jan-1970 05:30 is 0.00.

What is the P/B ratio of Venkat Pharma?

The latest P/B ratio of Venkat Pharma as of 01-Jan-1970 05:30 is -0.66.

What is the 52-week high and low of Venkat Pharma?

The 52-week high of Venkat Pharma is ₹3.72 and the 52-week low is ₹3.40.

What is the TTM revenue of Venkat Pharma?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Venkat Pharma is ₹0.00 ( Cr.) .

About Venkat Pharma Ltd

Venkat Pharma Ltd is a public limited company registered under the Indian Companies Act 1956 and their stock is listed in Bombay Stock Exchange (BSE) and is being actively traded. Established in 1989 it started manufacturing & sales of pharma products in 1992. The company is solely into the manufacturing and export of pharmaceutical products since their inception with an unswerving dedication.

At Venkat Pharma they meticulously manufacture pharma products, and constantly improvise existing product mix, thereby carving out a niche for themselves, in the global playing field of pharma.

Their philosophy is to provide value priced and quality pharmaceutical products to the humankind at large. At Venkat, they believe, that there is no compromise on the health of a human being. Their growth rate is quite above the industry CAGR growth rates as they are growing at a rate of 35% year on year.

Product range of the company includes:

API
PFIs
Finished Dosage
Under Development
Nutraceuticals

Milestones:

Floated as a Pvt. Ltd Company in 1989
Entered International Market in 1994
Became Public Ltd company in 1995
Issued an IPO in 1996
Listing in Bombay Stock Exchange in 1997
International market expansion via Product Registration Year 2000
Started APIs manufacturing in 2001
Strengthening of bottom line by trimming down less profitable products & markets in 2002
Expansions initiated in Regulated Markets

Achievements/ recognition :